Entity Common Stock, Shares Outstanding of PharmaCyte Biotech, Inc. from 19 Sep 2011 to 16 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PharmaCyte Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 19 Sep 2011 to 16 Dec 2025.
  • PharmaCyte Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 16 Dec 2025 was 10,134,160, a 45% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 10,134,160 +3,166,026 +45% 16 Dec 2025 10-Q 18 Dec 2025 2026 Q2
Q3 2025 6,795,779 -883,266 -12% 12 Sep 2025 10-Q 15 Sep 2025 2026 Q1
Q2 2025 6,795,779 -913,680 -12% 04 Aug 2025 10-K 11 Aug 2025 2025 FY
Q1 2025 6,863,699 -1,601,125 -19% 07 Mar 2025 10-Q 17 Mar 2025 2025 Q3
Q4 2024 6,968,134 -1,647,506 -19% 09 Dec 2024 10-Q 13 Dec 2024 2025 Q2
Q3 2024 7,679,045 -1,099,056 -13% 10 Sep 2024 10-Q 17 Sep 2024 2025 Q1
Q2 2024 7,709,459 -1,068,642 -12% 08 Aug 2024 10-K 13 Aug 2024 2024 FY
Q1 2024 8,464,824 -8,978,561 -51% 15 Mar 2024 10-Q 18 Mar 2024 2024 Q3
Q4 2023 8,615,640 -10,110,942 -54% 13 Dec 2023 10-Q 15 Dec 2023 2024 Q2
Q3 2023 8,778,101 -11,971,967 -58% 18 Sep 2023 10-Q 18 Sep 2023 2024 Q1
Q2 2023 8,778,101 -11,970,965 -58% 31 Jul 2023 10-K 31 Jul 2023 2023 FY
Q1 2023 17,443,385 -3,277,662 -16% 16 Mar 2023 10-Q 16 Mar 2023 2023 Q3
Q4 2022 18,726,582 -1,989,222 -9.6% 14 Dec 2022 10-Q 14 Dec 2022 2022 Q2
Q3 2022 20,750,068 +34,990 +0.17% 14 Sep 2022 10-Q 14 Sep 2022 2023 Q1
Q2 2022 20,749,066 +19,137,395 +1187% 28 Jul 2022 10-K 28 Jul 2022 2022 FY
Q1 2022 20,721,047 -2,364,404,627 -99% 15 Mar 2022 10-Q 15 Mar 2022 2022 Q3
Q4 2021 20,715,804 -2,314,094,601 -99% 14 Dec 2021 10-Q 14 Dec 2021 2022 Q2
Q3 2021 20,715,078 -2,313,095,327 -99% 14 Sep 2021 10-Q 14 Sep 2021 2022 Q1
Q2 2021 1,611,671 -2,332,198,734 -100% 09 Aug 2021 10-K 10 Aug 2021 2021 FY
Q1 2021 2,385,125,674 +903,654,502 +61% 12 Mar 2021 10-Q 12 Mar 2021 2021 Q3
Q4 2020 2,334,810,405 +942,939,233 +68% 11 Dec 2020 10-Q 11 Dec 2020 2021 Q2
Q3 2020 2,333,810,405 +1,005,639,233 +76% 11 Sep 2020 10-Q 11 Sep 2020 2021 Q1
Q2 2020 2,333,810,405 +1,005,639,233 +76% 11 Aug 2020 10-K 13 Aug 2020 2020 FY
Q1 2020 1,481,471,172 +354,566,667 +31% 13 Mar 2020 10-Q 13 Mar 2020 2020 Q3
Q4 2019 1,391,871,172 +264,966,667 +24% 20 Dec 2019 10-Q 23 Dec 2019 2020 Q2
Q3 2019 1,328,171,172 +248,671,212 +23% 12 Sep 2019 10-Q 13 Sep 2019 2020 Q1
Q2 2019 1,328,171,172 +287,132,750 +28% 12 Aug 2019 10-K 13 Aug 2019 2019 FY
Q1 2019 1,126,904,505 +113,643,861 +11% 14 Mar 2019 10-Q 14 Mar 2019 2019 Q3
Q4 2018 1,126,904,505 +153,236,694 +16% 14 Dec 2018 10-Q 14 Dec 2018 2019 Q2
Q3 2018 1,079,499,960 +106,332,149 +11% 12 Sep 2018 10-Q 12 Sep 2018 2019 Q1
Q2 2018 1,041,038,422 +67,870,611 +7% 20 Jul 2018 10-K 20 Jul 2018 2018 FY
Q1 2018 1,013,260,644 +137,952,034 +16% 19 Mar 2018 10-Q 19 Mar 2018 2018 Q3
Q4 2017 973,667,811 +123,763,146 +15% 14 Dec 2017 10-Q 14 Dec 2017 2018 Q2
Q3 2017 973,167,811 +124,263,146 +15% 12 Sep 2017 10-Q 13 Sep 2017 2017 Q1
Q2 2017 973,167,811 +125,113,146 +15% 26 Jul 2017 10-K 27 Jul 2017 2017 FY
Q1 2017 875,308,610 +103,225,384 +13% 13 Mar 2017 10-Q 13 Mar 2017 2017 Q3
Q4 2016 849,904,665 +99,077,842 +13% 02 Dec 2016 10-Q 02 Dec 2016 2017 Q2
Q3 2016 848,904,665 +105,476,036 +14% 06 Sep 2016 10-Q 06 Sep 2016 2017 Q1
Q2 2016 848,054,665 +105,443,836 +14% 29 Jul 2016 10-K 29 Jul 2016 2016 FY
Q1 2016 772,083,226 +64,315,245 +9.1% 07 Mar 2016 10-Q 08 Mar 2016 2016 Q3
Q4 2015 750,826,823 +51,534,794 +7.4% 10 Dec 2015 10-Q/A 19 Jan 2016 2016 Q2
Q3 2015 743,428,629 +33,407,711 +4.7% 24 Aug 2015 10-Q/A 19 Jan 2016 2016 Q1
Q2 2015 742,610,829 0 0% 28 Jul 2015 10-K/A 19 Jan 2016 2015 FY
Q1 2015 707,767,981 +69,484,767 +11% 13 Mar 2015 10-Q 13 Mar 2015 2015 Q3
Q4 2014 699,292,029 +105,880,681 +18% 15 Dec 2014 10-Q 15 Dec 2014 2015 Q2
Q3 2014 710,020,918 +72,779,570 +11% 15 Sep 2014 10-Q 15 Sep 2014 2015 Q1
Q2 2014 742,610,829 +232,679,481 +46% 28 Jul 2014 10-K 29 Jul 2015 2015 FY
Q1 2014 638,283,214 +178,500,389 +39% 17 Mar 2014 10-Q 17 Mar 2014 2014 Q3
Q4 2013 593,411,348 +147,782,097 +33% 13 Dec 2013 10-Q 16 Dec 2013 2014 Q2
Q3 2013 637,241,348 +213,290,497 +50% 13 Sep 2013 10-Q 16 Sep 2013 2014 Q1
Q2 2013 509,931,348 -7,889,503 -1.5% 29 Jul 2013 10-K 29 Jul 2013 2013 FY
Q1 2013 459,782,825 +85,345,244 +23% 25 Mar 2013 10-Q 26 Mar 2013 2013 Q3
Q4 2012 445,629,251 +68,966,670 +18% 21 Dec 2012 10-Q 26 Dec 2012 2013 Q2
Q3 2012 423,950,851 +70,563,270 +20% 10 Sep 2012 10-Q 19 Sep 2012 2013 Q1
Q2 2012 517,820,851 13 Aug 2012 10-K 14 Aug 2012 2012 FY
Q1 2012 374,437,581 20 Mar 2012 10-Q 21 Mar 2012 2012 Q3
Q4 2011 376,662,581 14 Dec 2011 10-Q 15 Dec 2011 2012 Q2
Q3 2011 353,387,581 19 Sep 2011 10-Q/A 20 Sep 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.